课题基金 / 基金详情

DsbA foldases from multidrug resistant pathogens as targets for new antimicrobials

DsbA foldases from multidrug resistant pathogens as targets for new antimicrobials
来自多重耐药病原体的 DsbA 折叠酶作为新型抗菌药物的靶点
批准号:
nhmrc : GNT1144046
负责人:
A/Pr Makrina Totsika
金额:
$74.34万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

A/Pr Makrina Totsika的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bacteria that cause common human infections, such as cystitis and diarrhoea, are now resistant to many antibiotics. If no action is taken, by 2050 antibiotic resistant infections will kill more people each year than cancer. This project aims to address this global public health crisis by characterising promising new bacterial targets and inhibitors designed to disarm multidrug resistant pathogens. Longer term this work could provide new infection therapies that are urgently needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DsbA inhibitors: from hits to leads
  • 批准号:
    nhmrc : GNT1099151
  • 项目类别:
    Project Grants
  • 资助金额:
    $88.3万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Makrina Totsika
  • 依托单位:
海外基金